Regeneron Pharmaceuticals, Inc.
2013 Q4 - 2025 Q4 (38 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 1/23/2026 | 202,114 | 0.3% | 261,850 | 12/31/2025 |
| 2025 Q3 | 10/22/2025 | 67,969 | 0.1% | 120,884 | 9/30/2025 |
| 2025 Q2 | 7/18/2025 | 25,047 | 0.0% | 47,708 | 6/30/2025 |
| 2025 Q1 | 4/23/2025 | 71,348 | 0.1% | 112,495 | 3/31/2025 |
| 2024 Q4 | 1/23/2025 | 92,110 | 0.2% | 129,308 | 12/31/2024 |
| 2024 Q3 | 10/29/2024 | 134,746 | 0.3% | 128,178 | 9/30/2024 |
| 2024 Q2 | 7/23/2024 | 133,412 | 0.3% | 126,935 | 6/30/2024 |
| 2024 Q1 | 4/24/2024 | 112,002 | 0.2% | 116,367 | 3/31/2024 |
| 2023 Q4 | 2/14/2024 | 105,650 | 0.3% | 120,291 | 12/31/2023 |
| 2023 Q3 | 10/24/2023 | 95,079 | 0.3% | 115,533 | 9/30/2023 |
| 2023 Q2 | 7/24/2023 | 88,269 | 0.2% | 122,845 | 6/30/2023 |
| 2023 Q1 | 5/4/2023 | 101,413 | 0.3% | 123,423 | 3/31/2023 |
| 2022 Q4 | 2/7/2023 | 88,778 | 0.3% | 123,048 | 12/31/2022 |
| 2022 Q3 | 12/1/2022 | 71,264 | 0.2% | 103,450 | 9/30/2022 |
| 2022 Q2 | 12/1/2022 | 48,919 | 0.2% | 82,760 | 6/30/2022 |
| 2022 Q1 | 12/1/2022 | 47,335 | 0.1% | 67,776 | 3/31/2022 |
| 2021 Q4 | 12/1/2022 | 31,856 | 0.1% | 50,445 | 12/31/2021 |
| 2021 Q3 | 12/1/2022 | 35,486 | 0.1% | 58,638 | 9/30/2021 |
| 2021 Q2 | 12/1/2022 | 20,802 | 0.0% | 37,244 | 6/30/2021 |
| 2021 Q1 | 12/1/2022 | 53,280 | 0.1% | 112,614 | 3/31/2021 |
| 2020 Q4 | 12/1/2022 | 76,557 | 0.2% | 158,473 | 12/31/2020 |
| 2020 Q3 | 1/19/2021 | 97,495 | 0.3% | 174,170 | 9/30/2020 |
| 2020 Q2 | 1/19/2021 | 96,742 | 0.3% | 155,120 | 6/30/2020 |
| 2020 Q1 | 1/19/2021 | 17,269 | 0.1% | 35,364 | 3/31/2020 |
| 2019 Q4 | 1/19/2021 | 4,909 | 0.0% | 13,074 | 12/31/2019 |
| 2019 Q3 | 1/19/2021 | 5,048 | 0.0% | 18,196 | 9/30/2019 |
| 2019 Q2 | 1/19/2021 | 6,057 | 0.0% | 19,346 | 6/30/2019 |
| 2019 Q1 | 1/19/2021 | 8,748 | 0.0% | 21,301 | 3/31/2019 |
| 2018 Q4 | 1/19/2021 | 4,984 | 0.0% | 13,370 | 12/31/2018 |
| 2018 Q3 | 1/19/2021 | 2,247 | 0.0% | 5,564 | 9/30/2018 |
| 2018 Q2 | 1/19/2021 | 1,575 | 0.0% | 4,564 | 6/30/2018 |
| 2018 Q1 | 1/19/2021 | 1,806 | 0.0% | 5,242 | 3/31/2018 |
| 2017 Q4 | 1/19/2021 | 391 | 0.0% | 1,038 | 12/31/2017 |
| 2017 Q3 | 1/19/2021 | 463 | 0.0% | 1,038 | 9/30/2017 |
| 2017 Q2 | 1/19/2021 | 504 | 0.0% | 1,026 | 6/30/2017 |
| 2017 Q1 | 1/19/2021 | 398 | 0.0% | 1,026 | 3/31/2017 |
| 2014 Q1 | 5/7/2014 | 185 | 0.0% | 616 | 3/31/2014 |
| 2013 Q4 | 2/4/2014 | 125 | 0.0% | 455 | 12/31/2013 |